MaaT Pharma SA (EPA: MAAT)
France flag France · Delayed Price · Currency is EUR
8.30
+0.14 (1.72%)
Nov 19, 2024, 5:35 PM CET

MaaT Pharma Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Market Capitalization
1158179132--
Upgrade
Market Cap Growth
18.94%2.32%-40.01%---
Upgrade
Enterprise Value
1015949123--
Upgrade
Last Close Price
8.246.988.0013.35--
Upgrade
PS Ratio
38.1336.3555.35135.75--
Upgrade
PB Ratio
4.483.962.953.31--
Upgrade
P/TBV Ratio
4.104.243.093.38--
Upgrade
EV/Sales Ratio
39.1726.4134.22126.09--
Upgrade
Debt / Equity Ratio
0.670.690.420.150.38-1.82
Upgrade
Asset Turnover
0.050.050.030.03-0.01
Upgrade
Inventory Turnover
8.917.4116.05---
Upgrade
Quick Ratio
2.612.654.389.937.750.70
Upgrade
Current Ratio
2.762.784.5710.057.760.71
Upgrade
Return on Equity (ROE)
-84.85%-83.41%-41.14%-32.33%-92.67%-
Upgrade
Return on Assets (ROA)
-29.99%-28.44%-18.00%-15.08%-20.62%-57.38%
Upgrade
Return on Capital (ROIC)
-34.70%-34.28%-20.21%-16.43%-25.55%-102.13%
Upgrade
Earnings Yield
-24.62%-24.34%-17.32%-6.84%--
Upgrade
FCF Yield
-16.52%-24.40%-16.76%-6.19%--
Upgrade
Buyback Yield / Dilution
-13.16%-14.89%-307.65%-135.06%--
Upgrade
Total Shareholder Return
-13.16%-14.89%-307.65%-135.06%--
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.